[1]Huang;McGowan;Detwiler[JournalofMedicinalChemistry,1992,vol.35,#11,p.2048-2054]
[1]Huang;McGowan;Detwiler[JournalofMedicinalChemistry,1992,vol.35,#11,p.2048-2054]
[1]Huang;McGowan;Detwiler[JournalofMedicinalChemistry,1992,vol.35,#11,p.2048-2054]
[1]Huang;McGowan;Detwiler[JournalofMedicinalChemistry,1992,vol.35,#11,p.2048-2054]
[1]Huang;McGowan;Detwiler[JournalofMedicinalChemistry,1992,vol.35,#11,p.2048-2054]
Title: Khan MS, et al. Design, synthesis, evaluation and thermodynamics of 1-substituted pyridylimidazo,5-apyridine derivatives as cysteine protease inhibitors. PLoS One. 2013 Aug 5;8(8):e69982.
Title: Toda G, et al. Calcium-activated neutral protease inhibitor (E-64c) and reperfusion for experimental myocardial infarction. Jpn Heart J. 1989 May;30(3):375-86.
Title: Radzey H, et al. E-64c-hydrazide: a lead structure for the development of irreversible cathepsin C inhibitors. ChemMedChem. 2013 Aug;8(8):1314-21.
Title: Ji Yeun Kim, et al. Safe, High-Throughput Screening of Natural Compounds of MERS-CoV Entry Inhibitors Using a Pseudovirus Expressing MERS-CoV Spike Protein. Int J Antimicrob Agents. 2018 Nov;52(5):730-732.
